回复@rafaello: 再加一个，原材料：MilliporeSigma Corp., Burlington, Massachusetts; and Sheboygan, Wisconsin, has been awarded a $136,695,430 definitive contract to establish domestic production capacity of lateral flow membranes for COVID-19 testing,Work will be performed in Sheboygan, Wisconsin, and is expected to be completed by Jan. 31, 2025.//@rafaello:回复@rafaello:最新获得的白宫已赞助列表：$481 million to Cue Health to expand production capability of POC COVID-19 tests
by 3 million tests/month.
• $231.8 million to Ellume to expand production capability of COVID-19 tests for athome OTC use by ~13 million tests/month.
• $200.58 million to expand production capability of laboratory-based testing by 66
million tests per month (Hologic Part I, Hologic Part II, BioFire Defense, Siemens,
Ortho Clinical, DiaSorin).
• $192.95 million to expand production capability of POC/OTC testing by 30.2 million
tests per month (BD Veritor, InBios, LightDeck, Luminostics, Princeton
Biomeditech, OraSure).